🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Networking at #MedTechCon is now easier than ever! With the new MyMedtech App, everything you need is in one place. View the full schedule, attendees list, and Exhibit Hall map. Discover potential partners and schedule meetings hassle free. Learn more: bit.ly/3Ll683n

The start-up I work for literally has 2 employees and we have a chance to WIN a video competition for our innovative medical device. Help me help patients! Here’s the video link to watch, like, and repost: youtube.com/watch?v=AECmlL…

📢ANNOUNCING: Opticyte is a finalist for the MedTech Innovator & AdvaMed Execution Award! The award recognizes strong leadership w/ next-generation innovations & resources to successfully execute their goals of improving patient care. Such an honor!🎊 medtechinnovator.org/medtech-innova…

It was an honor and privilege working with Opticyte at UW CoMotion Labs Fluke Hall. Working on life saving technology, being mindful of diversity in the field of medicine, and a team of wonderful people. Let’s go!

This week’s episode is dedicated entirely to the 10 Finalists of MedTech Innovator Pitch Competitions. The final winners will be selected by the audience on Oct. 10 at the upcoming AdvaMed annual meeting. LISTEN HERE: devicetalks.com/10-medtech-inn…

If you’re going to AdvaMed The MedTech Conference in next week, check-out Lori Arakaki’s presentation as part of the Critical Care & Emergency Medicine session on Monday, October 9. You’ll learn more about our transformative VitalO₂ device from its inventor! 💡 #FutureofHealthCare

Attending today’s FDA public meeting on #pulseox was inspiring. Clinicians, professional societies, regulators & patient reps all focused on improving pulse ox performance for people of all skin tones. It is clear there is a need and demand for a device like our VitalO₂.

Opticyte has been selected to pitch as part of a 30-company Creative Destruction Lab (CDL) Alumni Showcase later this month in Vancouver, BC. All the featured CDL Alumni ventures are seeking Series A/B capital and we can't wait to introduce our VitalO₂ technology to investors.

Congratulations Opticyte! Well deserved selection with an amazing group of companies. Says a lot about the work your team is doing!

Extraordinary interview with MP ⁦Craig Mackinlay⁩ about losing limbs to sepsis - if nothing else do take a minute to read the warning signs for sepsis, it’s so common (have family experience of this) & so easy to miss. bbc.co.uk/news/uk-politi…

Our CEO Lori Arakaki has the honor of being selected for this year's Project W WEB cohort! 🎉 A fantastic opportunity to meet and learn from mentors and experts focused on supporting female founders to raise the capital they need to build their #HealthTech companies.

We're honored to be featured by NIH NHLBI in this new article about our VitalO₂ device. NHLBI's non-dilutive funding for Opticyte has been essential for the product development and research on Cell O₂'s clinical value. A huge thank you to NHLBI for the support!

A study conducted by University of Washington and Providence Swedish used Opticyte's VitalO₂ monitor to collect data during cardiac surgery and recovery for correlation with vasoplegic shock. The study has now completed enrollment with Cell O₂ data on 60 patients! 🎉🎊

Spending hours in the OR and ICU for this study was such a learning opportunity for me. I’ll never forget the first time I watched an open-heart surgery! ❤️‍🩹 It’s really exciting for the study to have finished data collection and the analysis process to start in earnest.

Donating blood is patriotic. 4.2 million Americans need blood annually and each of them needs an average of 2.6 pints. So what better way is there to celebrate #IndependenceDay than with a blood #donation in July? Make an appointment w/ Bloodworks Northwest! 🌟 swedishnw.org/6011YFiu1